CONGENITAL/DEVELOPMENTAL DISORDERS {#cesec1}
==================================

Congenital Vestibular Disease {#cesec2}
-----------------------------

###  {#cesec3}

#### Definition and Causes {#cesec4}

I.Dysfunction of the peripheral vestibular system is seen in young dogs and cats, possibly from a congenital defect.II.The disorder is presumed to be inherited.III.It has been reported in the following breeds:A.Dogs: Doberman pinscher, American cocker spaniel, German shepherd dog, Akita, beagleB.Cats: Siamese, BurmeseIV.Aggregates of lymphocytes occur within the inner ear of affected Doberman puppies, but the significance of these lesions is unclear.

#### Clinical Signs and Diagnosis {#cesec5}

I.Onset of signs is usually 3 to 12 weeks of age.II.Head tilt, vestibular ataxia, circling, and deafness may be seen.III.Nystagmus is not a feature of this disorder.IV.Diagnosis is one of exclusion: rule out other causes of vestibular signs.

#### Differential Diagnosis {#cesec6}

I.Otitis media/internaII.Ototoxicity: aminoglycoside antibiotics, topical antiseptics (iodophors, chlorhexidine)

#### Treatment and Monitoring {#cesec7}

I.No treatment is available.II.Compensation for the vestibular signs may occur over several weeks.III.Deafness (if present) is typically permanent.

Hydrocephalus {#cesec8}
-------------

###  {#cesec9}

#### Definition {#cesec10}

I.It is an increase in the volume of cerebrospinal fluid (CSF) within the ventricular system or subarachnoid space of the brain ([@bib11]).II.In compensatory hydrocephalus, CSF accumulates in spaces within the cranial cavity not occupied by brain parenchyma.III.In obstructive hydrocephalus, obstruction to flow or absorption of CSF causes ventricular dilation (especially of the lateral ventricles) with subsequent loss of brain parenchyma.

#### Causes {#cesec11}

I.Compensatory hydrocephalus may result from the following:A.Developmental malformations: cerebral hypoplasia or aplasiaB.Destruction of brain parenchyma from in utero viral infections: feline panleukopeniaC.Cerebral necrosis secondary to cerebrovascular accidents: acquired hydrocephalusII.Obstructive hydrocephalus may result from the following:A.Fusion of rostral colliculi (midbrain) with CSF outflow obstruction at the mesencephalic aqueductB.Dysfunction of the arachnoid villi with poor reabsorption of CSF through the dorsal sagittal venous sinusIII.Acquired hydrocephalus may result from the following:A.Mass lesions blocking CSF flow: neoplasia, abscess, granulomaB.Neoplasia preventing CSF absorption by the arachnoid villiC.Infections (viral, bacterial) or inflammation of the ependyma of the mesencephalic aqueduct or leptomeninges blocking flow of CSFD.Intraventricular hemorrhage blocking CSF outflow: leptomeningeal, intraventricular

#### Clinical Signs {#cesec12}

I.No or variable signs may be seen, even in the presence of considerable ventricular dilatation.II.Prosencephalic signs include disturbed consciousness (lethargy to severe depression), increased tendency to sleep, hypoactivity, propulsive circling, head pressing, seizures, behavioral changes, dementia, and visual deficits (with normal pupillary responses).III.Motor deficits include spastic paresis, particularly if the brainstem is involved.IV.Occasionally cerebellar ataxia may occur if there is involvement of the cerebellum.V.Sensory deficits include proprioceptive ataxia.

#### Diagnosis {#cesec13}

I.Presumptive diagnosis is based on physical examination findings.A.Animals with congenital hydrocephalus often have palpable open fontanelles and develop a dome-shaped calvaria.B.Ventral-lateral strabismus may be noted.II.Imaging findingsA.Skull radiographs may reveal a homogenous "ground glass" appearance within the calvaria and open cranial suture lines.B.Ventriculomegaly may be demonstrated by computed tomography (CT), magnetic resonance imaging (MRI), and occasionally ultrasonography.

#### Differential Diagnosis {#cesec14}

I.Metabolic or toxic encephalopathiesII.MeningoencephalitisIII.Other congenital brain anomaliesIV.Degenerative encephalopathies

#### Treatment and Monitoring {#cesec15}

I.Corticosteroids may decrease CSF production.A.Prednisone 0.25 to 0.5 mg/kg PO BID, then tapered to QODB.Dexamethasone 0.05 mg/kg PO SID, then tapered to QODC.May be discontinued in some dogsII.Diuretics may decrease the volume of CSF.A.Furosemide 1 to 2 mg/kg PO BIDB.Acetazolamide 0.1 mg/kg PO TIDIII.Anticonvulsants may help control seizures.A.Phenobarbital 1 to 2 mg/kg PO BIDB.Potassium bromide (KBr) 20 to 30 mg/kg PO SIDIV.Ventriculoperitoneal shunting of CSF to the abdominal cavity may be effective in some cases that are refractory to medical management, but complications include infections and shunt failure.V.Prognosis is guarded to poor in severely affected animals.VI.Animals with minimal clinical signs can often be managed long term.

Hydranencephaly and Porencephaly {#cesec16}
--------------------------------

###  {#cesec17}

#### Definition {#cesec18}

I.Hydranencephaly is the congenital absence of a large portion of cerebrum in which cerebral cortex is absent and a fluid-filled, membranous sac takes its place ([@bib30]).II.Porencephaly is a disorder in which single or multiple cavities within the cerebrum usually communicate with the lateral ventricles or the subarachnoid space ([@bib30]).

#### Causes {#cesec19}

I.Hydranencephaly in cats is associated with in utero vaccine-induced feline panleukopenia infection.II.Porencephaly may occur when in utero infection with feline panleukopenia virus occurs later in the period of fetal central nervous system (CNS) vulnerability, or from less virulent viruses.

#### Pathophysiology {#cesec20}

I.The pathophysiology is not well understood.II.Parvoviral destruction of cerebral tissues is one potential mechanism.III.Hydranencephaly may arise from a fetal cerebrovascular accident that results in severe necrosis and resorption of cerebral tissue ([@bib5]).

#### Clinical Signs {#cesec21}

I.Signs typically occur within several weeks of birth and are proportional to the extent of cerebral loss.II.Prosencephalic signs include blindness and behavioral abnormalities, such as compulsive behavior, indifference to surroundings, episodes of rage, and central blindness.

#### Diagnosis {#cesec22}

I.Presumptive diagnosis is based on clinical signs.II.Antemortem diagnosis can be made with MRI or CT.

#### Differential Diagnosis {#cesec23}

I.Metabolic or toxic encephalopathiesII.MeningoencephalitisIII.Other congenital brain anomaliesIV.Degenerative encephalopathies

#### Treatment and Monitoring {#cesec24}

I.Treatment is similar to that for hydrocephalus.II.The prognosis is guarded to poor.

Lissencephaly and Pachygyria {#cesec25}
----------------------------

###  {#cesec26}

#### Definition and Cause {#cesec27}

I.Lissencephaly is a congenital abnormality in which the cerebral hemispheres have a smooth surface and absence of normal development of gyri and sulci ([@bib30]).II.Pachygyria is a condition in which the neocortex is much thicker than normal.III.In most cases the cause is unknown, but lissencephaly may be genetic in the Lhasa apso.

#### Pathophysiology {#cesec28}

I.The normal laminar pattern of the neuronal cell body organization is disrupted.II.Bundles of white matter are randomly scattered throughout a thick cortex.III.There is no development of corona radiata.

#### Clinical Signs {#cesec29}

I.Lissencephaly is most commonly observed in the Lhasa apso.II.Many dogs are difficult to house break but have relatively normal behavior.III.Prosencephalic signs include seizures starting around 1 year of age, behavioral changes, and visual deficits.

#### Diagnosis {#cesec30}

I.MRI reveals an absence of cerebral sulci and gyri, pachygyria, and decreased organization of white mater.II.Definitive diagnosis is made by postmortem examination.

#### Differential Diagnosis {#cesec31}

I.Metabolic or toxic encephalopathiesII.MeningoencephalitisIII.Other congenital brain anomalies, such as hydrocephalusIV.Degenerative encephalopathies

#### Treatment and Monitoring {#cesec32}

I.No definitive treatment exists.II.Treat seizures symptomatically with anticonvulsants (see Chapter 22).III.Prognosis is guarded.

CONGENITAL CEREBELLAR DISORDERS {#cesec33}
===============================

 {#cesec34}

###  {#cesec35}

#### Definition and Causes {#cesec36}

I.These include developmental defects or malformations of the cerebellum.II.The cause of most malformations is unknown; however, some may be genetic in origin.III.Hypoplasia can result from in utero infections with feline and canine parvoviruses ([@bib25]).

#### Pathophysiology {#cesec37}

I.MalformationsA.Various forms of cerebellar agenesis and hypoplasia have been reported in dogs ([@bib30]).B.A unique cerebellar malformation (Dandy-Walker syndrome) is characterized by a hypoplastic or aplastic cerebellum, cystic lesions of the caudal fossa or fourth ventricle, and hydrocephalus ([@bib30]).II.HypoplasiaA.The external germinal layer of the cerebellum is destroyed in utero by a parvovirus, with hypoplasia of the granule layer and disorganization of the Purkinje cells.B.Viruses or their resulting inflammation may destroy previously differentiated Purkinje neurons and cerebellar parenchyma, causing atrophy of the cerebellum ([@bib11]).

#### Clinical Signs {#cesec38}

I.Signs are present from the time the animal is able to walk and are usually nonprogressive.II.Signs include a wide stance, spastic-hypermetric gait (cerebellar ataxia), loss of balance, and intention tremors.

#### Diagnosis {#cesec39}

I.Presumptive diagnosis is based on clinical signs present at or soon after birth.II.Multiple animals in the litter may be affected.III.MRI may reveal a small cerebellum and increased amounts of CSF between the folia.IV.Definitive diagnosis is made by postmortem examination.

#### Differential Diagnosis {#cesec40}

I.Degenerative encephalopathiesII.Congenital cerebellar and abiotrophiesIII.Meningoencephalitis

#### Treatment and Monitoring {#cesec41}

I.No definitive treatment exists.II.Clinical signs are typically nonprogressive.III.Although signs persist, some animals make good pets.

Caudal Occipital Malformation and Syringohydromyelia {#cesec42}
----------------------------------------------------

###  {#cesec43}

#### Definition {#cesec44}

I.Occipital bone malformation and/or hypoplasia causes overcrowding of the caudal fossa and foramen magnum, obstruction of CSF, and syringohydromyelia.II.Syringohydromyelia is a fluid-filled cavity within the spinal cord (syrinx) and central canal (hydromyelia).

#### Causes and Pathophysiology {#cesec45}

I.Malformation of the occipital bone causes elongation and caudal displacement of the cerebellar vermis through the foramen magnum.II.The spinal cord is pushed caudally by the medulla and may have a kinked appearance.III.Occasionally, mild to moderate obstructive hydrocephalus is present.IV.Syringohydromyelia may develop secondarily, but the pathogenesis is uncertain.

#### Clinical Signs {#cesec46}

I.The Cavalier King Charles spaniel is overrepresented, but any breed may be affected.II.Affected animals range in age from 6 months to 10 years.III.Signs may manifest acutely or have an insidious course over months to years.IV.An unusual manifestation is the observation of paroxysmal involuntary flank or neck scratching in Cavalier King Charles spaniels.V.Spinal cord signs include cervical pain, cervical dystonia (torticollis), hyperesthesia, proprioceptive ataxia, abnormal postural reactions, varying degrees of paresis and hypermetria, and exercise intolerance.VI.Intracranial signs include seizures and deficits of cranial nerves VII and VIII.VII.Denervation of epaxial muscles and lesions in the dorsal tracks of the spinal cord can lead to muscle atrophy and scoliosis.

#### Diagnosis {#cesec47}

I.MRI reveals varying degrees of ventriculomegaly, syringohydromyelia, compression of the cerebellum by the occipital bone, caudal displacement and herniation of the cerebellar vermis, and obstruction of the subarachnoid space at the foramen magnum.II.CSF analysis occasionally reveals a mild elevation in nucleated cells and total protein.

#### Differential Diagnosis {#cesec48}

I.Intervertebral disc diseaseII.MeningoencephalitisIII.NeoplasiaIV.Atlantoaxial subluxation

#### Treatment and Monitoring {#cesec49}

I.Prednisone 0.5 mg/kg PO QOD may control signs ([@bib24]).II.Surgical management (subtotal occipital craniectomy, dorsal laminectomy of first cervical vertebra and durotomy to relieve obstruction) may be indicated for dogs with progressive signs ([@bib12]).III.Prognosis is fair to good depending on the severity of clinical signs.

DEGENERATIVE DISORDERS {#cesec50}
======================

Neuronal Abiotrophies and Dystrophies {#cesec51}
-------------------------------------

###  {#cesec52}

#### Definition and Causes {#cesec53}

I.Many of these disorders ([Table 23-1](#cetable1){ref-type="table"} ) are familial, hereditary, and cause degeneration of the CNS within the first few months of life ([@bib30]).TABLE 23-1Breed-Associated Degenerative Disorders of the BrainBREEDSDISEASEONSET AND CLINICAL SIGNSDIAGNOSIS**Cats**Birman catDistal central-peripheral axonopathy8-10 months; hypermetria, progressive paraparesis, plantigrade pelvic limb postureNerve biopsySpongiform encephalopathy7 weeks; hypermetria, paraparesis, depressionHistopathologyDomestic short- haired catNeuraxonal dystrophy5-6 weeks; head tremors, ataxia, hypermetriaHistopathologyEgyptian mauSpongiform encephalopathy7 weeks; hypermetria, paraparesis, depressionHistopathology**Dogs**Airedale terrierCerebellar degenerationCerebellar signs[\*](#cetablefn1){ref-type="table-fn"}HistopathologyCerebellar hypoplasiaCerebellar signsHistopathology, MRIAkitaCerebellar abiotrophyCerebellar signsHistopathology, MRIAmerican cocker spanielNeuronal degeneration10-14 months; behavior and personality changes, absent menace response, variable hypermetria and fallingHistopathologyCerebellar signs1-2 months; cerebellar signs that may stabilize by 12 monthsHistopathologyNeuraxonal dystrophy2-4 months; hypermetria, ataxia, intention tremorHistopathologyAustralian kelpieCerebellar abiotrophy6-12 weeks; cerebellar signsHistopathology, MRIBeagleCerebellar abiotrophy3 weeks; cerebellar signsHistopathology, MRIBernese mountainHypomyelination2-8 weeks; fine tremor of the head and limbs,Histopathology, MRIdogweakness, stiffness; may improve with ageBorder collieCerebellar abiotrophy6-8 weeks; cerebellar signsHistopathology, MRIBoxerProgressive axonopathy2 months; progressive ataxia and weakness; diminished proprioception, muscle tone, patellar reflexes; intact nociceptionEMG and nerve conduction studies, nerve biopsy, histopathologyBrittany spanielCerebellar abiotrophy7-13 years; progressive cerebellar signsHistopathology, MRIBullmastiffCerebellar abiotrophy4-9 weeks; progressive cerebellar signsHistopathology, MRISpongiosis of gray matter6-9 weeks; ataxia, hypermetria, intention tremor, decreased menace response, visual deficits, poor proprioceptionHistopathologyBull terrierCerebellar abiotrophyCerebellar signsHistopathology, MRICairn terrierCerebellar abiotrophyCerebellar signsHistopathology, MRIMultifocal neuronal degeneration4-7 months; progressive tetraparesis, cataplexy, cerebellar dysfunctionHistopathologyChow chowHypomyelination2-4 weeks; intention tremors, dysmetria, bunny hopping, improves after 1 yearHistopathology, MRIDalmatianLeukodystrophy3-6 months; visual deficits, progressive ataxiaHistopathologyEnglish springer spanielHypomyelination1-2 weeks; severe tremorsHistopathology, MRIFinnish harrierCerebellar abiotrophyCerebellar signsHistopathology, MRIGordon setterCerebellar abiotrophy6-30 months; slowly progressive cerebellar and vestibular signsHistopathology, MRIJack Russell terrierSpinocerebellar degeneration2-4 months; cerebellar ataxia, progressive dysmetria and spasticityHistopathologyKerry blue terrierCerebellar abiotrophy8-16 weeks; pelvic limb stiffness and head tremors, then dysmetriaHistopathology, MRILabrador retrieverCerebellar abiotrophy12 weeks; cerebellar signsHistopathology, MRIAxonopathyBirth; crouched, short-strided gait in thoracic limbs, hypermetria, unable to stand by 5 monthsHistopathologyOld English sheepdogCerebellar abiotrophyProgressive cerebellar signsHistopathology, MRIPapillonNeuroaxonal dystrophy14 weeks; rapidly progressive ataxia and hypermetria, decreased postural reactionsHistopathologyPoodleCerebellar abiotrophyCerebellar signsHistopathology, MRIRottweilerSpongiform degeneration with encephalomyelopathy and polyneuropathy6-16 weeks; progressive ataxia and dysmetria, laryngeal paralysis, congenital cataracts, microphthalmiaHistopathologyLeukoencephalopathy1-4 years; ataxia, tetraparesis, hypermetria, increased muscle tone/spinal reflexes, often more severe in thoracic limbsHistopathologyNeuraxonal dystrophyWithin 12 months; slowly progressive ataxia, hypermetria, wide-based stance, eventually intention tremors and nystagmusHistopathologyRough-coated collieCerebellar abiotrophy4-8 weeks; progressive cerebellar signsHistopathology, MRISalukiSpongiosis of gray matterBehavior changes, seizures, aimless wondering electroencephalographyHistopathologySamoyedHypomyelinationCerebellar abiotrophy3 weeks; generalized tremors, nystagmus, absent menace responseCerebellar signsHistopathology, possibly MRIHistopathology, MRIShetland sheepdogHypomyelination2-4 weeks; severe generalized tremors, difficulty standing, seizures, progressive debilitationHistopathology, MRIWeimaranerHypomyelination3 weeks; generalized tremors, dysmetria; several dogs normal by 12 monthsHistopathology, MRI[^1][^2]Adapted with permission from Platt RS, Olby N: BSAVA Manual of Canine and Feline Neurology. 3rd Ed. British Small Animal Veterinary Association, Quedgeley, England 2004.© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.II.Abiotrophies are characterized by early or premature neuronal degeneration and cell death.A.They are typically associated with an inherent lack of vital trophic or nutritive factors.B.They are categorized by the location of the affected neurons.1.Cerebellar abiotrophies are the most common and affect cerebellar Purkinje cells.2.Multisystem neuronal abiotrophies affect neurons throughout the CNS.3.Motor neuron abiotrophies affect motor neurons and cause lower motor neuron signs, with marked denervation atrophy and debilitating muscle contractures (arthrogryposis).III.Neuraxonal dystrophies are a group of inherited (often autosomal recessive) disorders characterized by axonal swellings (spheroids) in preterminal portions of axons and synaptic terminals.IV.Leukodystrophies (demyelinating disorders) are primary disorders of myelin synthesis.A.Leukodystrophies can involve CNS and peripheral nervous system (PNS) myelin.B.White matter involvement is usually regional, bilateral, and symmetrical.V.Hypomyelinogenesis is absent, delayed, or abnormal production of myelin.A.Histologically, oligodendrocytes are diminished in number or may be dysfunctional.B.An X-linked inheritance pattern is known or suspected.C.Other possible causes include in utero infections or intoxications.VI.Spongy degenerations are characterized by diffuse CNS vacuolation in the white and grey matter.VII.Axonopathies are characterized by diffuse CNS degeneration that result predominantly in encephalomyelopathies and neuropathies.A.A subset of these disorders (spinocerebellar degenerations) induces bilaterally symmetrical degeneration of ascending and descending tracts of the spinal cord.B.Despite lesions predominantly affecting the spinal cord, progressive cerebellar signs are seen clinically.

#### Clinical Signs {#cesec54}

I.With cerebellar abiotrophies, signs are noted in the first few weeks to months of life.A.Affected animals slowly develop progressive signs over months to years.B.Signs of cerebellar disease include a wide stance, spastic-hypermetric gait, loss of balance, intention tremors, and absent menace response.II.With neuraxonal dystrophies signs of spinal cord and cerebellar dysfunction occur.A.Lesions occur diffusely throughout the CNS, but spinal cord lesions predominate.B.Affected breeds include the rottweiler, Chihuahua, German shepherd dog, and domestic short-haired cat.III.Hypomyelinating disorders are characterized by generalized tremors, especially in the pelvic limbs.A.They often abate with rest.B.Signs may resolve spontaneously or persist indefinitely.

#### Diagnosis {#cesec55}

I.Diagnosis is suspected based on the signalment and clinical signs (see [Table 23-1](#cetable1){ref-type="table"}).II.MRI may be useful to demonstrate the distribution of lesions.III.Definitive diagnosis often requires postmortem examination.

#### Differential Diagnosis {#cesec56}

I.Disorders of intermediary metabolismII.Metabolic disordersIII.MeningoencephalitisIV.Neoplasia

#### Treatment and Monitoring {#cesec57}

I.No definitive treatment exists for these degenerative disorders.II.Prognosis is variable and often poor for long-term survival.

DISORDERS OF INTERMEDIARY METABOLISM {#cesec58}
====================================

 {#cesec59}

###  {#cesec60}

#### Definition and Causes {#cesec61}

I.These disorders are caused by inherited errors in intermediary metabolism that arise from abnormal or deficient enzyme systems ([@bib30]).II.Some disorders are storage diseases.

#### Pathophysiology {#cesec62}

I.Storage disorders are characterized by defective lysosomal enzymes that are catabolic or obligatory to cellular processes ([@bib27]).A.Loss or dysfunction of a degradative enzyme results in the accumulation of specific substrates in the lysosomes that distend cells with stored products.B.Lesions may be multisystemic or limited to the CNS and/or PNS.C.Most storage diseases are autosomal recessive traits ([Table 23-2](#cetable2){ref-type="table"} ).TABLE 23-2Disorders of Intermediary Metabolism (Storage Diseases)BREEDSDISEASEONSET AND CLINICAL SIGNSDIAGNOSIS**Cats**Balinese catNiemann-Pick type ACerebellar/vestibular signs, depression, peripheral neuropathyEnzyme assay in leukocytes, cultured fibroblastsDomestic short- haired catMannosidosisOnset \<6 months; connective tissue and skeletal malformation, possible peripheral neuropathyDNA testing[\*](#cetablefn2){ref-type="table-fn"}GM~1~ gangliosidosisCerebellar signs, dwarfism, facial dysmorphismOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin fibroblasts, liver, leukocytesGM~2~ gangliosidosisCerebellar/vestibular signsOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin fibroblasts, liver, leukocytesGloboid cell leukodystrophy (Krabbe\'s disease)Early cerebellar signs and ascending paralysis, cerebellar signs later or peripheral neuropathyDNA testing[†](#cetablefn3){ref-type="table-fn"}Peripheral nerve biopsy suggestiveEnzyme assay in leukocytes, cultured fibroblastsNiemann-Pick type CAtaxia, cerebellar/vestibular signs, peripheral neuropathy, possible hepatomegalyEnzyme assay in leukocytes or cultured fibroblastsMPS VIIProgressive paraparesisUrine metabolite screening[\*](#cetablefn2){ref-type="table-fn"}Mucolipidosis II (I-cell disease)Dysmorphism, failure to thrive, delayed skeletal mineralization and abnormalities, retinal degeneration at 2.5 months of ageInclusions in cultured fibroblasts, serum lysosomal enzyme assayKorat catGM~2~ gangliosidosisCerebellar/vestibular signsOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin fibroblasts, liver, leukocytesNorwegian forest catGlycogenosisIncoordination, exercise intoleranceDNA testing[\*](#cetablefn2){ref-type="table-fn"}PersianMannosidosisOnset at 8 weeks; connective tissue and skeletal malformation, possible peripheral neuropathyDNA testing[\*](#cetablefn2){ref-type="table-fn"}Oligosaccharide analysis in urineSiameseGM~1~ gangliosidosisCerebellar signs, dwarfism, facial dysmorphismOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin fibroblasts, liver, leukocytesNiemann-Pick type ACerebellar/vestibular signs, depression, peripheral neuropathyEnzyme assay in leukocytes and cultured fibroblastsMPS VIDysmorphism, paraparesis from spinal abnormalitiesDNA testing[\*](#cetablefn2){ref-type="table-fn"}Urine metabolite screening[\*](#cetablefn2){ref-type="table-fn"}**Dogs**AkitaGlycogenosis (type III)Muscular weakness, hepatomegalyLiver, muscle, nervous system pathologyBassett houndLafora\'s DiseaseMyoclonic epilepsyIntracytoplasmic PAS-positive inclusions in muscle biopsyBeagleGM~1~ gangliosidosisCerebellar signs, dwarfism, facial dysmorphismOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin biopsy fibroblasts, liver leukocytesLafora\'s DiseaseMyoclonic epilepsyIntracytoplasmic PAS-positive inclusions in muscle biopsyGloboid cell leukodystrophy (Krabbe\'s disease)Early cerebellar signs and ascending paralysis, cerebellar signs later or periheral neuropathyDNA testing[†](#cetablefn3){ref-type="table-fn"}Peripheral nerve biopsy suggestiveEnzyme assay in leukocytes, cultured fibroblastsBorder collieCeroid lipofuscinosisAdult and juvenile formsAtaxia, seizures, progressive blindness (central ± retinal)Lipopigment in skin biopsyBoxerNiemann-Pick type CAtaxia, cerebellar/vestibular signs, peripheral neuropathy, possible hepatomegalyEnzyme assay in leukocytes, cultured fibroblastsCairn terrierGloboid cell leukodystrophy (Krabbe\'s disease)Early cerebellar signs and ascending paralysis, cerebellar signs later or peripheral neuropathyDNA testing[†](#cetablefn3){ref-type="table-fn"}Peripheral nerve biopsy suggestiveEnzyme assay in leukocytes, cultured fibroblastsDachshundLafora\'s DiseaseMyoclonic epilepsyIntracytoplasmic PAS-positive inclusions in muscle biopsyCeroid lipofuscinosisAtaxia, seizures, progressive blindness (central ± retinal)Adult and juvenile formsLipopigment in skin biopsyDashshund, wire-hiredMPS III-AAtaxia, intention tremor, dysuriaUrine metabolite screening[\*](#cetablefn2){ref-type="table-fn"}English setterCeroid lipofuscinosisAtaxia, seizures, progressive blindness (cental ± retinal)Adult and juvenile formsLipopigment in skin biopsyEnglish springer spanielFucosidosisOnset at 1-4 years; cerebral signsDNA testing to detect carrier or affected dogs[\*](#cetablefn2){ref-type="table-fn"}GM~1~ gangliosidosisCerebellar signs, dwarfism, facial dysmorphismOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin fibroblasts, liver, leukocytesGlycogenosisIncoordination, exercise intoleranceLiver, muscle, nervous system pathologyGerman shepherd dogGlycogenosis (type III)Muscular weakness, hepatomegalyLiver, muscle, nervous system pathologyGerman short- haired pointerGM~2~ gangliosidosisCerebellar/vestibular signsOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin fibroblasts, leukocytesIrish setterGloboid cell leukodystrophy (Krabbe\'s disease)Early cerebellar signs and ascending paralysis, cerebellar signs later or peripheral neuropathyDNA testing[†](#cetablefn3){ref-type="table-fn"}Peripheral nerve biopsy suggestiveEnzyme assay in leukocytes, cultured, fibroblastsJapaneseGM~2~ gangliosidosisCerebellar/vestibular signsOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}spanielEnzyme assay in skin fibroblasts, liver, leukocytesLabrador retrieverMPS IIIncoordination, exercise intolerance, visual deficitsUrine metabolite screening[\*](#cetablefn2){ref-type="table-fn"}Lapland dogGlycogenosis (type II)Muscle weakness, vomiting, megaesophagus, cardiac and respiratory abnormalitiesLiver, muscle, nervous system pathology, EMG abnormalitiesMalteseMalonic aciduriaSeizures, stuporOrganic acid screening[\*](#cetablefn2){ref-type="table-fn"}Miniature pinscherMPS VIDysmorphism, paraparesis from spinal abnormalitiesDNA testing[\*](#cetablefn2){ref-type="table-fn"}Urine metabolite screening[\*](#cetablefn2){ref-type="table-fn"}Mix-breed dogsMPS VIIPelvic limb weakness, joint laxity, atrioventricular valve incompetenceDNA testing[\*](#cetablefn2){ref-type="table-fn"}Urine metabolite screening[\*](#cetablefn2){ref-type="table-fn"}Plott houndMPS IDysmorphism, paraparesis from spinal abnomalitiesUrine metabolite screening[\*](#cetablefn2){ref-type="table-fn"}PoodleGloboid cell leukodystrophy (Krabbe\'s disease)Early cerebellar signs and ascending paralysis, cerebellar signs later or peripheral neuropathyDNA testing[†](#cetablefn3){ref-type="table-fn"}Peripheral nerve biopsy suggestiveEnzyme assay in leukocytes, cultured fibroblastsPortuguese water dogGM~1~ gangliosidosisCerebellar signs, dwarfism, facial dysmorphismOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin fibroblasts, liver, leukocytesSiberian huskyGM~1~ gangliosidosisCerebellar signs, dwarfism, facial dysmorphismOligosaccharide analysis in urine[\*](#cetablefn2){ref-type="table-fn"}Enzyme assay in skin fibroblasts, liver, leukocytesSilky terrierGlucocerebrosidosis (Gaucher disease)Onset at 4-10 months; cerebellar signs, ataxia, seizures, dementiaEnzyme assay (β-glucosidase) in leukocytesStaffordshire bull terrierL-2-hydroxyglutaric aciduriaOnset at 6-8 months; ataxia, hypermetriaUrine organic acid screening[\*](#cetablefn2){ref-type="table-fn"}Sydney silky dogGlucocerebrosidosis (Gaucher disease)Ataxia, seizures, progressive blindness (central ± retinal)Adult and juvenile formsEnzyme assay in leukocytes, cultured fibroblastsTibetan terrierCeroid lipofuscinosisEarly cerebellar signs and ascending paralysis; late cerebellar signs or peripheral neuropathyLipopigment in skin biopsyWest highlandGloboid cellAtaxia, intention tremorDNA testing[†](#cetablefn3){ref-type="table-fn"}white terrierleukodystrophy (Krabbe\'s disease)Peripheral nerve biopsy suggestiveEnzyme assay in leukocytes, cultured fibroblasts[^3][^4][^5][^6]Adapted with permission from Platt RS, Olby N: BSAVA Manual of Canine and Feline Neurology. 3rd Ed. British Small Animal Veterinary Association, Quedgeley, England, 2004.© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.II.Disorders of intermediary metabolism affect enzyme systems that are not catabolic and do not result in stored substrate.A.They typically result in a unique, degenerative encephalopathy.B.Most are breed specific, with an autosomal recessive mode of inheritance (see [Table 23-2](#cetable2){ref-type="table"}).

#### Clinical Signs {#cesec63}

I.Signs often reflect diffuse CNS involvement; however, cerebellar signs often predominate in storage diseases.II.See [Table 23-2](#cetable2){ref-type="table"} for specific signs.

#### Diagnosis {#cesec64}

I.Diagnosis is often suspected based on signalment and clinical signs.II.DNA testing is available for some disorders (see [Table 23-2](#cetable2){ref-type="table"}).III.Diagnosis can be made through metabolite analysis of tissues or body fluids (urine or blood).

#### Differential Diagnosis {#cesec65}

I.Congenital cerebellar disorders or cerebellar abiotrophy (storage disorders)II.MeningoencephalitisIII.NeoplasiaIV.Other degenerative encephalopathies

#### Treatment and Monitoring {#cesec66}

I.Definitive treatment does not exist.II.Prognosis is variable and often poor for long-term survival.

INFECTIOUS DISORDERS {#cesec67}
====================

Rickettsial Meningoencephalitis {#cesec68}
-------------------------------

###  {#cesec69}

#### Definition and Causes {#cesec70}

I.Rickettsial disorders that can infect the brain include Rocky Mountain spotted fever *(Rickettsia rickettsii),* ehrlichiosis, and salmon poisoning ([@bib17]).II.Rocky Mountain spotted fever is transmitted by *Dermacentor andersoni*, *Dermacentor variabilis,* and *Amblyomma americanum* ticks.III.Canine ehrlichiosis *(Ehrlichia canis)* is transmitted by the brown dog tick, *Rhipicephalus sanguineus*.IV.Salmon poisoning *(Neorickettsia helminthoeca)* is acquired by consumption of salmonid and other fish that carry the metacercaria of the fluke, *Nanophyetus salmincola,* which is the intermediate host.

#### Clinical Signs {#cesec71}

I.Signs arise from a nonsuppurative meningoencephalitis composed mostly of plasma cells.II.See Chapter 115 for systemic signs.III.Neurological signs reflect diffuse brain involvement.

#### Diagnosis {#cesec72}

I.CSF analysis reveals a mononuclear pleocytosis, with mild to moderate elevations in protein content.II.A complete blood count (CBC) may reveal thrombocytopenia, anemia, and leukopenia early in the course, followed by leukocytosis.III.Intracytoplasmic ehrlichia morulae are occasionally identified in blood and CSF mononuclear cells.IV.Definitive diagnosis is based on elevated serum titers, a four-fold rise in antibody titer, or positive polymerase chain reaction (PCR) assays (see Chapters 2 and 115).

#### Differential Diagnosis {#cesec73}

I.Immune-mediated, noninfectious meningoencephalitisII.Other CNS infectionsIII.CNS neoplasia: lymphoma, metastatic neoplasia

#### Treatment and Monitoring {#cesec74}

I.Doxycycline is given 5 to 10 mg/kg PO BID for 2 to 3 weeks.A.Antibiotics may be effective if initiated early in disease course.B.Dogs may respond dramatically within 1 to 2 days, but prognosis is guarded to poor when severe neurological deficits are present.II.Recovery may be prolonged, and residual neurological deficits are possible.

Mycotic and Algal Infections {#cesec75}
----------------------------

###  {#cesec76}

#### Definition and Causes {#cesec77}

I.Most mycotic infections are regional diseases that produce pyogranulomatous inflammation of the CNS and are treated similarly ([@bib20]).A.Mycoses that may affect the CNS include *Cryptococcus ghatti*, *Blastomyces dermatitidis*, *Histoplasma capsulatum, Coccidioides immitis, Aspergillus* spp., phaeohyphomycosis, and hyalohyphomycosis.B.*Cryptococcus neoformans* may be the most common CNS mycotic infection.II.Protothecosis is a rare CNS infection of dogs caused by the achlorophyllous algae, *Prototheca wickerhamii* and *Prototheca zopfii*.

#### Pathophysiology {#cesec78}

I.Cryptococcosis is typically acquired from the environment (e.g., pigeon droppings, dead trees) rather than directly from infected animals.II.The natural route of these infections is thought to be via the respiratory tract, with subsequent hematogenous and lymphogenous dissemination.

#### Clinical Signs {#cesec79}

I.Clinical signs may reflect a focal mass lesion or a diffuse, multifocal process.II.Signs also reflect the location of the lesions within the CNS and are variable.III.A profound elevation in intracranial pressure may cause severe changes in mentation (depression, stupor, coma).IV.Ocular and nasal discharge may be noted.V.See Chapter 111 for systemic signs.

#### Diagnosis {#cesec80}

I.Diagnosis of cryptococcosis utilizes the latex agglutination test (LAT), which detects capsular antigen in serum, urine, or CSF.II.Serological testing for other agents is described in Chapters 2 and 111.III.CSF analysis sometimes reveals cryptococcal organisms by staining with India ink.A.Mononuclear, neutrophilic, or eosinophilic pleocytosis, and elevated protein levels are often present.B.Fungal culture of CSF is usually unrewarding.IV.MRI may show multiple inflammatory lesions that are hypointense on T1-weighted images and hyperintense on T2-weighted images, with multifocal parenchymal and leptomeningeal enhancement.

#### Differential Diagnosis {#cesec81}

I.Immune-mediated, noninfectious meningoencephalitisII.Other CNS infectionsIII.CNS neoplasia: lymphoma, metastatic neoplasia

#### Treatment and Monitoring {#cesec82}

I.Amphotericin B may be given at 0.1 to 0.5 mg/kg IV, SC three times weekly.A.Animals treated with amphotericin B require weekly assessment of renal function, and it is contraindicated in animals with renal dysfunction.B.Liposome encapsulated preparations may be safer.II.Imidazole drugs may be tried alone or in conjunction with amphotericin.A.Fluconazole 5 to 15 mg/kg PO BID (preferred)B.Itraconazole 5 to 10 mg/kg PO BIDIII.For cryptococcosis, the LAT is monitored monthly during treatment.A.Treatment is discontinued after two negative LAT tests are documented 1 month apart or 1 month after resolution of clinical signs.B.Treatment is often prolonged (3 to 12 months).C.Prognosis is guarded, especially for disseminated disease.

Canine Distemper Encephalomyelitis {#cesec83}
----------------------------------

###  {#cesec84}

#### Definition and Cause {#cesec85}

I.Canine distemper virus is a multisystemic disease affecting the respiratory, alimentary, urogenital, ocular, and nervous systems in dogs.II.It is an RNA Morbillivirus of the family Paramyxoviridae.

#### Pathophysiology {#cesec86}

I.Several forms and stages of CNS disease exist ([@bib30]).II.Lymphocytic meningoencephalomyelitis occurs during the first week of exposure.A.No neurological signs are seen during this phase.B.Infection may be self-limiting or may progress to affect either grey or white matter (more commonly).III.Grey matter disease occurs approximately 1 week after initial infection.A.Typical sites of infection include the cerebral cortex, brainstem, and spinal cord.B.Grey matter disease typically occurs in puppies at 6 to 12 weeks of age; certain viral strains may cause disease in adult dogs.C.Postvaccinal disease (inadequately attenuated virus) can occur 7 to 10 days after vaccination and may result in severe brainstem lesions and death.D.Old-dog encephalitis is a rare, chronic form of the disease.E.Pathologic lesions include neuronal degeneration, gliosis, and eosinophilic inclusions in neurons and glial cells.IV.White matter disease is the most common form of infection and occurs approximately 1 month after initial infection.A.Demyelination is the hallmark finding.B.Lesions occur in sites that are adjacent to CSF path-ways (optic tracts, hippocampus, cerebellar peduncles, spinal cord).C.White matter lesions may be noninflammatory for 1 month, then progress to nonsuppurative meningitis and perivascular encephalitis.D.Inflammatory lesions ultimately become necrotizing.E.Eosinophilic inclusions can be observed in glial cells.

#### Clinical Signs {#cesec87}

I.With grey matter disease, signs reflect nonsuppurative meningitis.A.Seizures, stupor, hysteria, and ataxia can be observed.B.Dogs may die within 2 to 3 weeks, recover, or develop white matter disease.II.With white matter disease, signs are multifocal and variable.A.Commonly observed signs include cerebellovestibular ataxia and spinal cord paresis.B.Occasionally myoclonus develops of a single limb or the temporalis and/or masseter muscles.C.Some dogs die 4 to 5 weeks after initial infection, and some may recover with minimal CNS injury.D.Other dogs may have persistent CNS demyelination and nonsuppurative inflammation, with or without clinical signs.

#### Diagnosis {#cesec88}

I.Presumptive diagnosis is based on history, signalment, vaccination status, and clinical signs, especially in nonvaccinated dogs.II.Immunofluorescent or immunocytochemical techniques can detect canine distemper viral antigen in brain sections and other tissues (mononuclear cells in blood, conjunctival or tracheal washes, foot pad biopsies).III.CSF analysis reveals moderate pleocytosis of mononuclear cells (lymphocytes, macrophages).A.Neutralizing antibody in CSF develops 2 to 3 weeks after onset of disease.B.The immunoglobulin G (IgG) index (calculated quotient of IgG and albumin levels in CSF compared to serum that detects intrathecal IgG synthesis) is elevated in most dogs except those with acute, noninflamma-tory distemper.IV.Reverse transcriptase PCR of urine, CSF, and conjunctival swabs may identify the virus.

#### Differential Diagnosis {#cesec89}

I.Affected puppies: congenital and developmental diseasesII.Immune-mediated or noninfectious meningoencephalitisIII.Other causes of infectious meningoencephalitis: bacteria, parasites, protozoa, rickettsiaIV.Other viral CNS infectionsA.Borna disease (staggering disease), LaCrosse virusB.Canine herpesvirusC.RabiesD.Tickborne encephalitis virusE.Eastern equine encephalitis virusF.West Nile virusV.CNS neoplasia: lymphoma, metastatic disease

#### Treatment and Monitoring {#cesec90}

I.No definitive treatment exists for the virus.II.Treatment is largely supportive (fluid therapy, nutritional support).III.Euthanasia is considered for dogs with progressive neurological signs that lead to incapacitation.

Feline Infectious Peritonitis Meningoencephalitis {#cesec91}
-------------------------------------------------

###  {#cesec92}

#### Definition and Cause {#cesec93}

I.Feline infectious peritonitis (FIP) is a fatal, systemic immunopathologic disease caused by a feline coronavirus.II.Although meningitis may accompany the more acute form of peritoneal exudation, a second form affects the CNS and eye with little or no peritoneal involvement ([@bib13]).

#### Pathophysiology {#cesec94}

I.The underlying pathogenesis involves a type III immune reaction and immune complex-induced vasculitis.II.This CNS infection is characterized by meningitis, ependymitis, and encephalomyelitis ([@bib30]).III.The mesencephalic aqueduct may be obstructed, causing hydrocephalus and hydromyelia.IV.Focal brain or spinal cord lesions may also occur.

#### Clinical Signs {#cesec95}

I.Signs are usually nonspecific, but often include profound cerebellovestibular involvement.II.Signs from focal lesions reflect the site of the lesion.III.See Chapter 112 for systemic signs.

#### Diagnosis {#cesec96}

I.Antemortem diagnosis is very challenging.II.CSF analysis reveals profound neutrophilic or mono-nuclear pleocytosis, with high elevations of protein.III.Identification of antibody titers in CSF is supportive.IV.Serum titers are difficult to interpret (see Chapter 112).V.Serum hypergammaglobulinemia and increased fibrino-gen levels may occur.VI.MRI may show marked dilation of the ventricular system and enhancement of ependymal (periventricular) surfaces and the choroid plexus.VII.Definitive diagnosis requires histopathology.

#### Differential Diagnosis {#cesec97}

I.Congenital or developmental diseasesII.CNS neoplasia: lymphosarcomaIII.Other viral diseases: feline immunodeficiency virus, Borna diseaseIV.Bacterial meningoencephalitisV.Toxoplasmosis

#### Treatment and Monitoring {#cesec98}

I.Because no definitive treatment exists, supportive care (fluid therapy, nutritional support) may be tried.II.Prednisone 2 to 4 mg/kg PO SID to BID may provide palliative relief.III.The prognosis is grave for long-term survival.

Bacterial Meningoencephalitis {#cesec99}
-----------------------------

###  {#cesec100}

#### Definition and Causes {#cesec101}

I.It is inflammation of the brain and/or meninges from aerobic or anaerobic bacterial infections.II.Organisms that can infect the CNS include *Pasteurella, Staphylococcus, Actinomyces, Nocardia, Streptococcus,* and *Klebsiella* spp., and *Eschericia coli*.

#### Pathophysiology {#cesec102}

I.A variety of mechanisms allow bacterial entry into the CNS.A.Hematogenous spread from distant foci: lung abscess, vegetative endocarditis, urinary tract infectionB.Direct extension from nasal and paranasal sinuses, ears, and eyesC.Secondary to trauma and wound contamination (bite wound)D.Meningeal spread along nerve rootsE.Contaminated surgical instruments: spinal needlesII.Organisms usually disseminate through CSF pathways and produce meningitis and microabscesses of the brain and spinal cord.III.Formation of inflammatory cytokines and tumor necrosis factor by monocytes and neural cells leads to altered blood-brain barrier permeability, recruitment of neutrophils, and purulent exudates in the subarachnoid space.IV.Vasculitis leads to vasogenic brain edema.V.Toxic oxygen metabolites released from degranulating leukocytes also cause cytotoxic brain edema.

#### Clinical Signs {#cesec103}

I.Clinical signs begin acutely.II.Systemic signs include fever, vomiting, bradycardia, ano-rexia, shock, and hypotension.III.Neurological signs consist of hyperesthesia, cervical pain and rigidity (common), seizures (occasionally), and cranial nerve deficits ([@bib23]).

#### Diagnosis {#cesec104}

I.CSF analysis typically shows a profound neutrophilic pleocytosis and protein elevation.A.Organisms sometimes may be seen on CSF cytology.B.Bacterial culture of CSF (aerobic and anaerobic) provides a definitive diagnosis, but negative cultures do not rule out the disease.II.Blood and urine cultures may yield a pathogenic organism.III.A CBC may reveal a neutrophilic leukocytosis and left shift.IV.MRI and CT can show meningeal, brain and/or ventricular enhancement, as well as abscessation.

#### Differential Diagnosis {#cesec105}

I.Immune-mediated meningoencephalitis, especially steroid-responsive meningitis/arteritisII.Intervertebral disc diseaseIII.Other CNS infectionsIV.CNS neoplasia: lymphoma, metastatic neoplasiaV.Systemic bacterial infections

#### Treatment and Monitoring {#cesec106}

I.Preferred antibiotic therapy is based on culture results and is continued for several weeks after clinical signs have resolved.II.Empirical treatment choices in dogs are as follows:A.Chloramphenicol 50 mg/kg IV, IM, SC, PO BIDB.Metronidazole 10 to 15 mg/kg PO TIDC.Enrofloxacin 10 mg/kg IV, PO SIDD.Azithromycin 5 to 10 mg/kg PO SIDE.Trimethoprim-sulfonamide 15 to 30 mg/kg PO BIDIII.Corticosteroids are generally contraindicated, but antiinflammatory doses may be beneficial upon initiation of treatment.IV.Prognosis is guarded.A.Death is common even if appropriate therapy is administered.B.Relapses are frequently encountered.

Toxoplasmosis {#cesec107}
-------------

###  {#cesec108}

#### Definition and Cause {#cesec109}

I.Toxoplasmosis may be the most common protozoa to affect the CNS in dogs and cats.II.The causative agent is *Toxoplasma gondii.*

#### Pathophysiology {#cesec110}

I.Organisms may form cysts in the CNS and in the skeletal and heart muscles.II.Parasites are mainly intracellular, and subclinical infection may persist for life.III.Activation may occur with severe immunosuppression, especially from viral infections.IV.Nonsuppurative (focal or multifocal) necrotizing meningoencephalomyelitis occurs in the CNS, whereas radiculitis and myositis develop in the PNS.V.Chorioretinitis commonly accompanies CNS lesions.VI.Lesions may also occur in lungs, liver, spleen, and lymph nodes.

#### Clinical Signs {#cesec111}

I.The disease most commonly affects animals \<1 year of age or animals that are immunocompromised.II.Clinical signs relate to either focal (granulomas) or multifocal CNS disease.III.Possible signs include hyperexcitability, depression, intention tremors, paresis, paralysis, head tilt, and seizures.IV.Spinal cord signs are more common in cats.V.See Chapter 116 for systemic signs.

#### Diagnosis {#cesec112}

I.Definitive diagnosis is often difficult to establish (see Chapter 116).II.CSF analysis may demonstrate a mononuclear, neutrophilic, or eosinophilic pleocytosis, with elevated protein levels.III.PCR may reveal the presence of the organism in CSF, muscle, or liver biopsies.IV.Electromyography (EMG) may show abnormal spontaneous activity in animals with muscle and nerve involve-ment, and nerve conduction velocities may be decreased in animals with nerve involvement.V.MRI or CT may reveal focal or multifocal CNS lesions.

#### Differential Diagnosis {#cesec113}

I.DogsA.*Neospora caninum* 1.Most often affects dogs \<2 years of age2.Predilection for lumbosacral nerve roots (radiculitis, neuritis, see Chapter 24)3.May cause encephalitis (especially cerebellitis) in adult dogsB.Sarcocystosis, encephalitozoonosis, trypanosomiasisC.Acanthamebiasis, babesiosisD.LeishmaniasisE.Autoimmune, bacterial, viral meningoencephalitisF.Neoplasia: lymphosarcoma, histiocytic tumorsII.CatsA.FIPB.Neoplasia: lymphosarcomaC.Borna diseaseD.Bacterial meningoencephalitis

#### Treatment and Monitoring {#cesec114}

I.Clindamycin is the drug of choice and is given at 10 to 20 mg/kg PO, IM BID for 3 to 6 weeks.II.Alternatively, trimethoprim-sulfonamide (15 to 20 mg/kg PO BID) is combined with pyrimethamine at 1 mg/kg PO SID for 4 to 8 weeks.III.Prognosis is guarded with CNS involvement, but some animals survive with minimal residual neurological deficits.

NONINFECTIOUS INFLAMMATORY DISORDERS {#cesec115}
====================================

Granulomatous Meningoencephalomyelitis {#cesec116}
--------------------------------------

###  {#cesec117}

#### Definition and Cause {#cesec118}

I.Granulomatous meningoencephalomyelitis (GME) is an idiopathic (mononuclear) meningoencephalomyelitis that most commonly occurs in young to middle-age dogs.II.GME is thought to be an immune-mediated (delayed-type hypersensitivity) disease based on the presence of major histocompatibility complex class II and cluster differentiation (CD3) antigen-positive lymphocytes ([@bib19]).

#### Pathophysiology {#cesec119}

I.Three morphological forms exist, namely disseminated, focal, and ocular disease ([@bib30]).II.Lesions consist of perivascular, concentric proliferations of inflammatory cells predominantly in the white matter.III.Perivascular cellular accumulations consist of lymphocytes, plasma cells, and mononuclear cells.

#### Clinical Signs {#cesec120}

I.Onset ranges from 9 months to 10 years of age.II.Signs may be acute, rapidly progressive and fatal, or chronic and insidious.III.The focal form of GME results in focal deficits, whereas the disseminated form causes multifocal signs.IV.Neurological signs reflect lesion location and distribution.A.Brainstem (varying degrees of depression and spastic tetraparesis, vestibular ataxia, head tilt, abnormal nystagmus) and cerebellar signs are most common.B.Prosencephalic signs include seizures, depression, circling, and visual deficits.C.The ocular form causes visual deficits, anisocoria, and abnormalities in pupillary light reflexes.V.A fever is often present.

#### Diagnosis {#cesec121}

I.The CSF usually reveals a mild to severe pleocytosis of monocytes and lymphocytes, with mild protein elevation.II.MRI and CT may reveal multifocal lesions, predominantly in the white matter of the CNS.III.Definitive diagnosis requires histopathology.

#### Differential Diagnosis {#cesec122}

I.Necrotizing meningoencephalitisII.Necrotizing leukoencephalitisIII.Infectious meningoencephalitisIV.CNS neoplasia: lymphoma, metastatic neoplasia

#### Treatment and Monitoring {#cesec123}

I.Immunosuppression is the primary therapy.II.Prednisone is given at 1.0 to 3.0 mg/kg PO BID for 1 month, then gradually tapered over several months to 0.5 mg/kg PO SID to QOD.III.Additional drugs may allow a reduction in prednisone and ameliorate its side effects.A.Cytosine arabinoside 50 mg/m^2^ SC BID for 2 days, repeated every 3 weeks ([@bib34])B.Cyclosporine 5 to 10 mg/kg PO BID ([@bib1])C.Others: leflunomide, procarbazine, CCNU (lomustine)IV.Radiation therapy may be beneficial for the focal form.V.GME is rarely cured and often requires lifelong therapy to control the inflammation.

Necrotizing Meningoencephalitis {#cesec124}
-------------------------------

###  {#cesec125}

#### Definition and Cause {#cesec126}

I.It is an idiopathic meningoencephalitis of young pugs, Maltese, Shih tzus, and occasionally other small-breed dogs ([@bib9]; [@bib29]).II.It is presumed to be an immune-mediated disease.

#### Pathophysiology {#cesec127}

I.Lesions consist of nonsuppurative meningoencephalitis and mild cerebral necrosis.II.It typically affects the cerebral hemispheres, with inflammation extending from the leptomeninges through the cortex and into the corona radiata.III.This pattern leads to a loss of demarcation between cortical grey and white matter in the brain.

#### Clinical Signs {#cesec128}

I.Onset ranges from 9 months to 4 years of age.II.Signs may be rapidly progressive and fatal.III.Signs consist of prosencephalic signs, such as seizures, depression, circling, and visual deficits.IV.Motor and sensory problems (ataxia, paresis), brainstem and cerebellar signs are also possible.

#### Diagnosis {#cesec129}

I.CSF analysis shows a moderate to severe pleocytosis composed of monocytes and lymphocytes, with mild protein elevation.II.MRI findings mirror the topography of the histopathologic lesions.III.MRI typically demonstrates multifocal lesions in the superficial cortical grey matter at the junction of the cerebrum and leptomeninges.

#### Differential Diagnosis {#cesec130}

I.Granulomatous meningoencephalomyelitisII.Necrotizing leukoencephalitisIII.Infectious meningoencephalitisIV.CNS neoplasia: lymphoma, metastatic neoplasiaV.Metabolic, toxic encephalopathiesVI.Other causes of seizures: see Chapter 22

#### Treatment and Monitoring {#cesec131}

I.Immunosuppression is the primary therapy and is similar to that for GME.II.The prognosis is grave.III.If a response is seen to immunosuppression, lifelong therapy is necessary to control the inflammation.

Necrotizing Leukoencephalitis {#cesec132}
-----------------------------

###  {#cesec133}

#### Definition and Cause {#cesec134}

I.It is an idiopathic (mononuclear) meningoencephalitis of young Yorkshire terriers, Chihuahuas, and occasionally other small-breed dogs ([@bib31]).II.It is presumed to be an immune-mediated disease.

#### Pathophysiology {#cesec135}

I.Lesions consist of nonsuppurative meningoencephalitis and moderate to severe cerebral necrosis.II.Gross cavitations occur in periventricular cerebral and diencephalic (thalamocortical) white matter.

#### Clinical Signs {#cesec136}

I.Onset is from 1 to 5 years of age.II.The clinical course is slowly progressive, usually over many weeks to months.III.Clinical signs reflect caudal brainstem or prosencephalic lesions.IV.Brainstem signs often predominate and include varying degrees of depression, spastic tetraparesis, vestibular ataxia, head tilt, and abnormal nystagmus.V.Prosencephalic signs consist of seizures, propulsive activity, and visual deficits.

#### Diagnosis {#cesec137}

I.The CSF analysis usually reveals a moderate to severe pleocytosis of monocytes and lymphocytes and a mild protein elevation.II.MRI and CT may show multifocal cavitating lesions predominantly in deep white matter.

#### Differential Diagnosis {#cesec138}

I.Granulomatous meningoencephalomyelitisII.Necrotizing meningoencephalitisIII.Infectious meningoencephalitisIV.CNS neoplasia: lymphoma, metastatic neoplasiaV.Metabolic or toxic encephalopathiesVI.Other causes of seizures: see Chapter 22

#### Treatment and Monitoring {#cesec139}

I.Immunosuppression is the mainstay of therapy (see under GME).II.The prognosis is grave and therapy may be life-long.

Canine Meningeal Polyarteritis {#cesec140}
------------------------------

###  {#cesec141}

#### Definition and Cause {#cesec142}

I.The disease is a neutrophilic meningitis of young dogs that is characterized by episodes of severe pain, depression, and fever ([@bib10]).II.It is presumed to be immune-mediated.III.It is also known as *steroid-responsive* (or *sterile*) *meningitis-arteritis, immune-mediated meningitis, Beagle pain syndrome, systemic necrotizing vasculitis,* and *juvenile polyarteritis syndrome.*

#### Pathophysiology {#cesec143}

I.Inflammation occurs in the leptomeningeal arteries.II.Leptomeningeal vascular lesions may be accompanied by lymphocytic thyroiditis, amyloidosis (splenic, hepatic, renal), or polyarthritis ([@bib32]).

#### Clinical Signs {#cesec144}

I.Affected dogs range in age from 6 months to a few years.II.It affects the beagle, Bernese mountain dog, boxer, German short-haired pointer, and is sporadically reported in other breeds.III.The predominant clinical signs are profound neck pain, depression, anorexia, and fever.IV.Occasionally, ataxia and varying degrees of paresis are also present (see Chapter 24).V.The clinical course is typically acute in onset.

#### Diagnosis {#cesec145}

I.Signalment and clinical signs are suggestive.II.CSF analysis reveals the following:A.CSF has a severe neutrophilic pleocytosis, with excessive protein and phagocytosed red blood cells (RBCs).B.Neutrophils in CSF do *not* show toxic changes, and intracellular bacteria are not observed.C.CSF aerobic and anaerobic bacterial cultures are negative.D.Consistent elevation of CSF and serum immunoglobulin (Ig) A concentrations occur.III.Occasionally peripheral neutrophilia with a left shift and an elevated serum α2-globulin fraction are found.IV.CT or MRI may demonstrate contrast enhancement of the meninges, spinal cord, or brain.

#### Differential Diagnosis {#cesec146}

I.Intervertebral disc diseaseII.Bacterial meningoencephalitisIII.Other immune-mediated meningoencephalitidesIV.CNS neoplasia

#### Treatment and Monitoring {#cesec147}

I.Long-term immunosuppression is achieved with prednisone at 1 to 2 mg/kg PO BID, then tapered monthly over 6 months.II.In refractory cases, azathioprine (1.5 mg/kg PO SID to QOD) may be added and eventually alternated with prednisone QOD.III.Prognosis is guarded to favorable; recurrences are common.IV.Monitor for recurrences, and consider repeating the CSF analysis if clinical signs persist.

Eosinophilic Meningoencephalitis {#cesec148}
--------------------------------

###  {#cesec149}

#### Definition and Cause {#cesec150}

I.Eosinophilic meningoencephalitis is an uncommon disease, primarily of rottweilers and golden retrievers, that is characterized by severe, multifocal neurological signs ([@bib28]; [@bib26]).II.It is presumed to be an immune-mediated disease.

#### Clinical Signs {#cesec151}

I.Prosencephalic signs consist of behavioral and mentation changes, circling, pacing, head pressing, blindness, and generalized or partial seizures.II.Brainstem signs include episodic collapse, facial paralysis, absent gag reflex, reduced pupillary light reflexes, torticollis, and varying degrees of ataxia and incoordination.

#### Diagnosis {#cesec152}

I.CSF analysis shows variable pleocytosis, with 21% to 98% eosinophils, and elevated protein content.II.Mild to moderate systemic eosinophilia may be observed.III.Serology for infectious diseases is negative.

#### Differential Diagnosis {#cesec153}

I.Other CNS infections: primary protozoal, fungal, parasiticII.Other noninfectious meningoencephalitidesIII.CNS neoplasia

#### Treatment and Monitoring {#cesec154}

I.Prednisone therapy (and possibly additional immunosuppressive agents) is instituted similar to that for GME.II.Prognosis is favorable to guarded.

IDIOPATHIC DISORDERS {#cesec155}
====================

Idiopathic Tremor Syndrome {#cesec156}
--------------------------

###  {#cesec157}

#### Definition and Cause {#cesec158}

I.Idiopathic tremor syndrome (shaker dog disease) is a meningoencephalitis of young, small, white dogs ([@bib11]).II.Occasionally, dogs with pigmented coats are affected.III.The exact pathogenesis remains uncertain, although it may be immune-mediated.IV.Mild lymphoplasmacytic meningoencephalitis is the predominant lesion.

#### Clinical Signs {#cesec159}

I.It most commonly affects Maltese and West Highland white terriers.II.Other affected breeds include the bichon frisé, Spitz, samoyed, beagle, dachshund, and Yorkshire terrier.III.The predominant clinical sign is continuous, whole-body tremors that worsen with exercise, stress, and excitement, but disappear with sleep.IV.Neurological examination often is normal, with the exception of generalized tremors.V.When present, neurological signs may include absent menace response, spontaneous nystagmus, poor to absent oculocephalic reflexes (physiological nystagmus), vestibular or cerebellar ataxia, head tilt, varying degrees of paresis, and seizures.

#### Diagnosis {#cesec160}

I.CSF analysis reveals mild lymphocytic pleocytosis, with normal or mildly elevated protein levels.II.MRI typically is normal, but may disclose symmetrical ventricular enlargement in some dogs.

#### Differential Diagnosis {#cesec161}

I.Metabolic or toxic encephalopathiesII.MeningoencephalitisIII.Dysmyelinogenic disorders

#### Treatment and Monitoring {#cesec162}

I.Prednisone is administered at 1 to 2 mg/kg PO SID for 4 weeks, then tapered to 0.5 to 1 mg/kg PO SID for 2 weeks, then to QOD for 2 weeks, then to every 72 hours for 4 weeks.II.Diazepam 0.25 mg/kg PO BID to TID or propanolol 1 mg/kg PO TID may be beneficial in refractory cases.III.Prognosis is favorable, with tremors usually decreasing by the end of the first week of therapy.IV.Relapses can occur and may require additional immunosuppressive therapy (e.g., azathioprine).

Trigeminal Neuropathy {#cesec163}
---------------------

###  {#cesec164}

#### Definition and Cause {#cesec165}

I.It is an idiopathic disorder characterized by acute onset of trigeminal nerve paresis or paralysis ([@bib11]).II.It may be an immune-mediated condition.

#### Clinical Signs {#cesec166}

I.Clinical signs include an acute onset of jaw paresis or paralysis with an inability to close the mouth, drooling, and difficult prehension of food and water.II.Trigeminal sensory deficits are common.III.Horner\'s syndrome (from effects on postganglionic sympathetic fibers incorporated in segments of the ophthalmic branch of the trigeminal nerve) is occasionally seen.IV.Occasionally, the facial nerve is also involved.

#### Diagnosis {#cesec167}

I.EMG of the muscles of mastication is abnormal.II.CSF analysis may reveal a mild mononuclear pleocytosis, often with normal or mildly elevated protein content.III.Definitive diagnosis of trigeminal neuropathy requires biopsy of the trigeminal nerve, but it is rarely done.

#### Differential Diagnosis {#cesec168}

I.Lymphoma infiltrating the trigeminal nervesII.PolyradiculoneuritisIII.RabiesIV.Masticatory muscle myositis

#### Treatment and Monitoring {#cesec169}

I.The condition is often self-limiting, with recovery occurring over 3 to 4 weeks to several months.II.Corticosteroids do not seem to affect the clinical course.III.Fluid and nutritional support may be necessary for animals unable to eat and drink on their own.IV.The severity of muscle atrophy, clinical course, and recovery depends upon the extent of axonal degeneration.V.Prognosis is favorable in most cases, but can be guarded in severely affected animals.

Idiopathic Facial Nerve Paralysis {#cesec170}
---------------------------------

###  {#cesec171}

#### Definition and Cause {#cesec172}

I.It is a disorder of mature dogs and cats that is character-ized by facial palsy or paralysis ([@bib18]).II.The cause is unknown.

#### Clinical Signs {#cesec173}

I.Predisposition exists in the American cocker spaniel, Pembroke Welsh corgi, boxer, English setter, and domestic long-haired cat.II.Clinical signs include ear drooping, commissural paralysis of the lip, sialosis, deviation of the nose away from the affected side, and collection of food on the paralyzed side of the mouth.III.Menace response and palpebral reflexes are absent ipsilaterally.IV.Facial paralysis is usually unilateral, but may be bilateral in some animals.V.Horner\'s syndrome is not seen.

#### Diagnosis {#cesec174}

I.Diagnosis is often presumptive, based on clinical signs and exclusion of other disorders.II.EMG may reveal spontaneous denervation potentials in superficial facial muscles.

#### Differential Diagnosis {#cesec175}

I.Polyradiculoneuritis (coonhound paralysis)II.Endocrine disorders: hypothyroidism, insulinomaIII.Laryngeal paralysis syndromeIV.Myasthenia gravis, botulismV.Trauma near the stylomastoid foramen or in conjunction with petrosal bone fractureVI.Middle ear infection, neoplasiaVII.Surgery of the external or middle ear, or side of the faceVIII.Extracranial tumors

#### Treatment and Monitoring {#cesec176}

I.Application of ophthalmic lubricants helps prevent corneal drying.II.Prognosis for a complete return to function is guarded.III.Chronic lip paralysis may result in permanent contracture, and the inability to close the eyelids often leads to keratitis.

Peripheral Vestibular Syndrome {#cesec177}
------------------------------

###  {#cesec178}

#### Definition and Cause {#cesec179}

I.It is an acute disorder that occurs in cats of all ages and in older dogs ([@bib11]).II.Mechanism and cause are unknown.III.Most feline cases (80%) occur in the summer ([@bib8]).

#### Clinical Signs {#cesec180}

I.Clinical signs occur acutely.II.Only signs of peripheral vestibular dysfunction (no evidence of facial nerve paralysis or Horner\'s syndrome) are present.III.Signs include head tilt, asymmetrical ataxia, and horizontal or rotatory nystagmus with the fast phase directed away from the head tilt.IV.More severe signs of falling, rolling, and vomiting (especially in dogs) are seen occasionally.

#### Diagnosis {#cesec181}

I.Presumptive diagnosis is based on signalment, history, clinical signs, and exclusion of other etiologies.II.Absence of otoscopic and radiographic abnormalities of the middle ear is supportive.III.MRI or CT scan is normal.IV.CSF analysis is normal.

#### Differential Diagnosis {#cesec182}

I.Otitis media/internaII.NeoplasiaIII.Cerebrovascular accident of brainstem

#### Treatment and Monitoring {#cesec183}

I.Supportive care is administered, as needed.II.Affected animal tends to stabilize in a few days and improve gradually over several weeks.III.Prognosis for spontaneous remission is good; however, residual deficits (e.g., mild head tilt) may occur.

PARASITIC DISORDERS {#cesec184}
===================

Parasitic Encephalomyelitis {#cesec185}
---------------------------

###  {#cesec186}

#### Definition {#cesec187}

I.Aberrant migration of parasite larvae through the CNS results in parenchymal damage and neurological signs ([@bib7]).II.It is also known as *cerebral larval migrans.*

#### Causes {#cesec188}

I.*Toxocara canis*II.*Ancylostoma caninum*III.*Angiostrongylus cantonensis*IV.*Dirofilaria immitis*V.*Angiostrongylus vasorum*VI.*Cysticercus cellulosae*VII.*Baylisascaris procyonis*VIII.*Coenurus serialis*

#### Pathophysiology {#cesec189}

I.Migrating larvae damage neural tissue by two mechanisms.II.Necrosis can occur in tissue along the migratory pathway.III.Migrating larvae evoke an inflammatory response, which causes ischemia, edema, and toxic injury to myelin, axons, and neurons.

#### Clinical Signs {#cesec190}

I.Clinical signs are acute in onset and rapidly progressive.II.Signs reflect the location of the migratory pathway.A.Prosencephalon signs include blindness, circling, behavioral changes, seizures, and postural reaction deficits.B.Brainstem signs include varying degrees of ataxia and paresis, changes in mentation, cranial nerve deficits, head tilt, and spontaneous nystagmus.C.Cerebellar signs include a wide stance; a spastic, hypermetric gait; loss of balance; intention tremors; and absent menace response.III.Neurological signs may reflect focal or multifocal disease.

#### Diagnosis {#cesec191}

I.CSF is characterized by an eosinophilic or neutrophilic pleocytosis, and protein elevation.II.A positive test for *D. immitis* is suggestive.III.Definitive diagnosis requires histological demonstration of the parasite within the CNS.

#### Differential Diagnosis {#cesec192}

I.Infectious meningoencephalitisII.Eosinophilic meningoencephalomyelitisIII.GMEIV.Neoplasia

#### Treatment and Monitoring {#cesec193}

I.No successful therapy to dateII.Guarded prognosis

Intracranial Myiasis {#cesec194}
--------------------

###  {#cesec195}

#### Definition and Cause {#cesec196}

Aberrant migration of *Cuterebra* spp. larvae can occur within the CNS of cats and dogs (rarely) ([@bib16]).

#### Pathophysiology {#cesec197}

I.Larvae may migrate through the nose, ethmoids, and cribriform plate and enter the brain through the olfactory lobe.II.Alternatively, larvae can migrate through foramina of the skull, travel through the external and middle ear, penetrate the mastoid region, invade venous sinuses and meninges, or enter hematogenously after penetrating a large vessel.III.Microscopic necrosis of the brain occurs secondary to ischemia.IV.Lesions are usually unilateral in regions supplied by the middle cerebral artery (see Cerebral Vascular Disease).V.It is hypothesized that the larvae produce a toxin that causes vasospasm and cerebral infarction and may cause superficial laminar cerebrocortical necrosis ([@bib33]).

#### Clinical Signs {#cesec198}

I.Animals are often affected in summer months, when adult flies deposit their ova.II.Typically outdoor cats (rarely dogs) are affected.III.Many cats have signs consistent with upper respiratory disease (especially sneezing) before the appearance of neurological signs.IV.Neurological signs are peracute in onset.V.Prosencephalic signs, including unilateral postural reaction deficits, unilateral facial (and occasionally whole-body) hypalgesia, and a menace deficit with a dilated, nonresponsive pupil from involvement of the optic tracts are noted.VI.Seizures and profound behavioral and mentation changes are often present.

#### Diagnosis {#cesec199}

I.CSF analysis may be normal or show a mild to moderate pleocytosis (neutrophilic, mononuclear, or occasionally eosinophilic), with mild protein elevation.II.MRI may reveal the migratory path of the larvae, cerebrocortical lesions, and evidence of a focal or regional infarction.III.Definitive diagnosis requires histopathology.

#### Differential Diagnosis {#cesec200}

I.Other infectious or parasitic meningoencephalitisII.Eosinophilic meningoencephalitisIII.Neoplasia

#### Treatment and Monitoring {#cesec201}

I.The following may be beneficial, but controlled studies have not been done.A.Pretreat with diphenhydramine 4 mg/kg IM.B.Give ivermectin 400 μg/kg SC and dexamethasone 0.1 mg/kg IV.C.Repeat the treatment 24 to 48 hours later.II.A third-generation cephalosporin, trimethoprim-sulfa drug, or metronidazole may be given to prevent bacterial infection associated with larval migration.III.Although prognosis is guarded; some cats may recover over weeks to months with residual neurological deficits.

METABOLIC/TOXIC DISORDERS {#cesec202}
=========================

General Information {#cesec203}
-------------------

###  {#cesec204}

#### Definition and Causes {#cesec205}

I.These include disturbances in cerebral function from metabolic derangements or toxicoses that usually manifest as diffuse prosencephalic signs.II.See [Table 23-3](#cetable3){ref-type="table"} for a list of causes.TABLE 23-3Causes of Metabolic or Toxic EncephalopathiesDISORDERCAUSESHypoxiaCardiopulmonary failure, disturbances in hemoglobin function, carbon monoxide poisoning, methemoglobinemia, cellular hypoxia (cyanide poisoning)HypoglycemiaPancreatic beta-cell tumor (insulinoma), iatrogenic insulin overdose, hepatic dysfunction, septicemia, hypoadrenocorticism, paraneoplastic syndromes (e.g., leiomyosarcoma, hepatoma, lymphoma), neonatal animals, hunting dogs, storage diseasesAcidosis, alkalosis, hyperosmotic statesHyperglycemia (diabetes mellitus), hypernatremia, dehydration, diabetes insipidus, nonketotic, hyperosmolar diabetes mellitus, hyperaldosteronismHypoosmotic states, hyponatremiaHypoadrenocorticism, water intoxication, inappropriate secretion of antidiuretic hormoneAlterations in calcium homeostasis HypercalcemiaParaneoplastic syndromes, rodenticide toxicity (cholecalciferol-containing products), hyperparathyroidism, Vitamin D toxicity, renal disease, hypoadrenocorticism, certain granulomatous diseases HypocalcemiaEclampsia, hypoparathyroidismEndogenous neurotoxinsHepatic insufficiency/failure, renal failure, pancreatitisEndocrine disordersHyperthyroidism, hypothyroidism

#### Pathophysiology {#cesec206}

I.Energy deprivation leads to alterations in neuronal resting membrane potentials, and may disrupt neurotransmitter function and metabolism.II.Certain toxins and metabolic abnormalities may interfere with energy metabolism in the brain, potentially causing neuronal death.III.Electrolyte imbalances may alter neuronal excitability and neurotransmission.IV.Changes in serum osmolality and water content lead to altered osmotic balance in neural cells, which may cause either brain cell swelling (edema) or dehydration.

#### Clinical Signs {#cesec207}

I.Metabolic encephalopathies typically cause diffuse, symmetrical prosencephalic signs, such as seizures, altered mentation (confusion, disorientation, dementia, pacing, head pressing), circling, and altered consciousness (obtundation, stupor, coma).II.Onset may be acute or chronic, and signs may wax and wane.III.Motor signs include tremors, myoclonus, and varying degrees of paresis/paralysis.

#### Diagnosis {#cesec208}

I.Other evidence of metabolic disturbances may be identified from the history or the physical examination.II.A minimum laboratory database includes a complete blood count, biochemistry profile, and urinalysis.III.Other diagnostic tests are considered based on initial findings.A.Serum bile acidsB.Blood gas analysisC.Measurement of serum osmolalityD.Endocrine function testsE.Cardiopulmonary function tests: electrocardiography, blood pressure measurement, radiography, echocardiographyF.Abdominal radiography and ultrasonography

#### Differential Diagnosis {#cesec209}

I.Degenerative encephalopathiesII.MeningoencephalitisIII.NeoplasiaIV.Brain malformations

#### Treatment and Monitoring {#cesec210}

I.Ensure an adequate airway; support breathing and circulation if the animal is comatose.II.Correct the underlying metabolic disturbance.III.Consider anticonvulsants for seizures.IV.Take care when treating seizures in animals with hepatic insufficiency, because they are unable to metabolize many anticonvulsants.A.Give diazepam (0.5 mg/kg IV), but reduce the dosage if hepatic encephalopathy is a primary concern.B.Give phenobarbital initially at 2.0 mg/kg PO, IV, IM BID, with caution.1.Metabolism may be compromised with hepatic dysfunction.2.Acidosis causes increased penetration of barbiturates into the brain.C.Seizures may be difficult to control until the under-lying metabolic imbalance is corrected.V.Administer dextrose if hypoglycemia is identified (see Chapter 46).VI.In most cases, neurological signs resolve once the metabolic disturbance is corrected.

Hepatic Encephalopathy {#cesec211}
----------------------

See Chapter 37.

Cerebrovascular Disease {#cesec212}
-----------------------

###  {#cesec213}

#### Definition {#cesec214}

I.Cerebrovascular disease refers to conditions that result in brain ischemia, infarction, or hemorrhage.II.These conditions include the following:A.Cerebrovascular accidents: thromboembolism and infarction, hemorrhage ([@bib15])B.Vascular anomalies: aneurysm, hamartomaC.Cerebral arteriosclerosis secondary to severe hypothyroidismD.MeningoencephalitisE.Intravascular neoplasms: lymphoma

#### Causes and Pathophysiology {#cesec215}

I.Cerebral ischemia occurs as a result of insufficient blood supply to the brain.A.Dogs may have transient ischemic attacks, possibly from vasospasm.1.Attacks are often of unknown etiology.2.Occasionally they are associated with hypertension.B.Feline ischemic encephalopathy (FIE) occurs in the late summer, most commonly in eastern North America.1.Aberrant migration of *Cuterebra* spp. larva is thought to be the primary cause ([@bib16]).2.It is hypothesized that a toxin from the larva causes vasospasm (of the middle cerebral artery), resulting in a unilateral ischemic brain lesion ([@bib33]).II.Hypoperfusion of the brain is associated with atherothrombosis or embolism.A.With atherothrombosis, a localized thrombus forms and disrupts blood flow, with subsequent ischemia and/or infarction.B.With embolization, an artery is suddenly occluded, usually by a thrombus that arises from a distant site, such as in the heart (blood clot) or a neoplasm (e.g., neoplastic cells from hemangiosarcoma).III.Systemic hypoperfusion causes a decrease in cerebral blood flow and can lead to infarction in the border zones between major cerebral arteries (watershed infarction).IV.Impaired blood supply to the brain results in a decline in tissue oxygen levels (stagnant hypoxia), which cause brain ischemia.

#### Clinical Signs {#cesec216}

I.Clinical signs are peracute and may be followed by progressive recovery over days to weeks.II.Clinical signs reflect the location of brain infarction.III.Although gait deficits are not typically seen with prosencephalic lesions, a transient gait deficit (hemiparesis) may be seen with prosencephalic infarcts.IV.Vestibular signs may be seen with thalamic infarcts.

#### Diagnosis {#cesec217}

I.Serial blood pressure measurements may indicate hypertension.II.Results of a CBC, biochemistry profile, and urinalysis vary, depending on the presence of an underlying systemic disease.III.Additional tests may include urine protein: creatinine ratio, serum antithrombin III activity, coagulation profile, and endocrine testing for hyperadrenocorticism, thyroid diseases, and pheochromocytoma.IV.Thoracic radiography and abdominal ultrasonography may reveal evidence of an underlying disease.V.MRI (and occasionally CT) may reveal ischemic brain lesions.VI.CSF analysis usually shows normal to mild increases in nucleated cells, with elevated protein content.

#### Differential Diagnosis {#cesec218}

I.MeningoencephalitisII.Metabolic encephalopathyIII.Neoplasia

#### Treatment and Monitoring {#cesec219}

I.No definitive treatment for the neurologic signs has been defined in animals.II.Osmotic therapy (as described for cranial trauma) may be beneficial in severely affected animals.III.Treatment is usually directed at the underlying disease.IV.Prognosis and recovery are highly variable.

NUTRITIONAL DISORDERS {#cesec220}
=====================

Thiamine Deficiency {#cesec221}
-------------------

###  {#cesec222}

#### Definition and Causes {#cesec223}

I.Metabolic encephalopathy can arise from thiamine deficiency ([@bib11]).II.Commercial rations or homemade diets may be low in thiamine.III.Overcooking food before feeding or during food processing can affect thiamine levels.IV.Thiamine can be destroyed by sulfites or sulfur dioxide used as a preservative in canned food.V.All-fish diets may result in thiamine deficiency, as many fish contain thiaminase.VI.Severe hepatic or renal disease can be associated with thiamine deficiency.

#### Pathophysiology {#cesec224}

I.Thiamine is essential for complete oxidation of glucose through the Krebs cycle.II.Tissues that derive energy from glucose or lactate-pyruvate are compromised.III.Several proposed mechanisms for neuronal cell death include impaired vascular function, increased blood-brain barrier permeability, N-methyl-D-aspartic acid receptor-mediated excitotoxicity, and increased free radical formation ([@bib21]).IV.CNS lesions include bilateral, symmetrical degeneration of brainstem nuclei (caudal colliculi, vestibular, lateral geniculate, oculomotor and red nuclei), and cortical lesions (less common).

#### Clinical Signs {#cesec225}

I.Signs are related to dysfunction of brainstem nuclei and include vestibular ataxia, seizures, dilated pupils, opisthotonus, coma, and death.II.Severe head and neck ventriflexion is often present from neuromuscular weakness.III.Dogs may have signs of central (bilateral) vestibular disease or cervical myelopathy ([@bib14]).

#### Diagnosis {#cesec226}

I.History, signalment, clinical signs, and response to treatment allow a presumptive diagnosis.II.MRI may disclose symmetrical lesions in affected brainstem nuclei ([@bib14]).III.Serum levels of pyruvate and lactate may be increased.IV.Red blood cell transketolase activity is usually decreased.

#### Differential Diagnosis {#cesec227}

I.MeningoencephalitisII.Metabolic or toxic encephalopathiesIII.NeoplasiaIV.Other causes of central vestibular disease

#### Treatment and Monitoring {#cesec228}

I.Even in severely affected animals, prognosis is fair to good if signs are recognized early.II.Thiamine HCl (vitamin B~1~) is administered at 25 to 50 mg/day IM to dogs for 3 to 7 days, and at 10 to 20 mg/day IM to cats until signs abate, or for 21 days.III.Higher doses may be required in some animals.IV.Dietary abnormalities should also be corrected.

NEOPLASIA {#cesec229}
=========

 {#cesec230}

###  {#cesec231}

#### Definition {#cesec232}

I.Primary brain tumors arise from neuroectodermal or mesodermal cells that are normally present within or associated with the brain ([@bib30]).II.Secondary tumors originate from surrounding tissues and extend into the brain or arise from hematogenous metastasis.III.Classification of brain tumors (primary or secondary) is based on characteristics of the constituent cell types ([@bib4]).

#### Causes and Classification {#cesec233}

I.Primary tumorsA.Tumors of neuroepithelium1.Astrocytic tumors: astrocytoma, glioblastoma multiforme2.Oligodendroglial tumors: oligodendroglioma3.Mixed glial tumors: oligoastrocytoma, gliomatosis cerebri4.Embryonal tumors: primitive neuroectodermal tumors (PNETs), medulloblastoma5.Ependymoma6.Choroid plexus tumorsB.Tumors of meninges: meningioma, meningeal sarcomaC.Tumors of hematopoietic tissue: lymphoma, histiocytic tumorsD.Nerve sheath tumorsE.Tumors of the sellar region1.Pituitary tumors: adenoma, adenocarcinoma2.Suprasellar germ cell tumorsII.Metastatic tumorsA.HemangiosarcomaB.Urogenital tumors: prostatic carcinoma, mammary gland adenocarcinomaC.Malignant melanomaIII.Secondary tumors of adjacent tissuesA.Tumors arising from the calvaria: osteosarcoma, multilobulated tumor of boneB.Local extension of regional tumors1.Nasal tumor: adenocarcinoma, fibrosarcoma2.Tumors arising from the ear or osseous bullae: adenocarcinoma, squamous cell carcinoma

#### Pathophysiology {#cesec234}

I.Direct effects of tumor growth include compression and invasion of normal brain parenchyma.II.Indirect effects are often more significant than direct effects.A.Damage to the blood-brain barrier can result in cerebral edema.B.Obstruction to CSF flow causes secondary hydrocephalus.C.Brain herniation can occur as a result of increased intracranial pressure from an enlarging space-occupying mass within the rigid calvaria.D.Hemorrhage is also a possibility.

#### Clinical Signs {#cesec235}

I.Breed predisposition has been reported for several tumors.A.Brachycephalic breeds (especially the boxer, English bulldog, and Boston terrier) are predisposed to gliomas (astrocytomas, oligodendrogliomas, mixed tumors) and pituitary tumors.B.Dolichocephalic dogs and Siamese cats may be predisposed to meningiomas.II.Onset of disease may be acute or insidious, depending on the location, rate of growth, and indirect effects of the tumor.III.Neurological signs reflect the location of the tumor.A.Cerebral or thalamic tumors (prosencephalic tumors) may cause seizures, circling, behavioral changes, contralateral postural reaction deficits, contralateral visual deficits, and contralateral nasal hypalgesia.B.Brainstem tumors can induce vestibular signs, ipsilateral postural reaction deficits, cranial nerve deficits, ataxia (both proprioceptive and vestibular), and changes in mentation.C.Cerebellar tumors can result in a wide stance; spastic, hypermetric gait (cerebellar ataxia); loss of balance; intention tremors; ipsilateral postural reaction deficits; and ipsilateral, absent menace response without visual deficits.D.Tumors of the floor of the calvaria may cause deficits of the oculomotor, trochlear, abducens nerves, and the ophthalmic branch of the trigeminal nerve.1.Disruption of the sympathetic innervation to the head may also occur.2.Clinical signs may include ophthalmoplegia, Horner\'s syndrome, mydriasis, and trigeminal sensory deficits involving the eye and the medial canthus.IV.Metastatic tumors may involve single or multiple areas within the CNS and be associated with focal or multifocal signs.V.Tumors involving the frontal and olfactory lobes of the cerebrum may cause seizures or changes in mentation without other deficits.

#### Diagnosis {#cesec236}

I.A minimum database includes a CBC, biochemistry pro-file, urinalysis, and three radiographic views of the thorax.II.MRI and CT may allow a presumptive diagnosis.A.Meningiomas often are extraaxial (on the periphery of the brain), have a broad-based attachment, and exhibit strong, homogeneous contrast enhancement.B.Glial tumors often are intraaxial (within brain parenchyma), display variable contrast enhancement, and occasionally have a ring-enhancement pattern.C.Choroid plexus tumors are located intraventricularly or at the cerebellomedullary angle and typically exhibit strong, uniform contrast enhancement.D.Tumors can occur in the ventricles, such as choroid plexus and ependymal tumors.E.Secondary consequences include compression of normal brain structures with shifting of midline structures, obstructive hydrocephalus, and cerebral (vasogenic) edema.III.CSF analysis often reveals nonspecific abnormalities.A.An increased protein concentration and a normal cell count are typical.B.Neoplastic lymphocytes may be seen with lymphoma.C.Meningiomas may result in a neutrophilic pleocytosis from tumor necrosis.D.An increased risk of brain herniation is associated with elevated intracranial pressure and is a contraindication to CSF tap.IV.Definitive diagnosis requires histopathologic evaluation.

#### Differential Diagnosis {#cesec237}

I.Metabolic or toxic encephalopathiesII.Meningoencephalitis: infectious, noninfectiousIII.Vascular disordersIV.Other causes of seizures, altered mentation

#### Treatment and Monitoring {#cesec238}

I.Certain treatments are directed at the secondary consequences.A.Osmotic diuretics are used to draw edema out of the brain.1.Give mannitol at 0.25 to 1.0 g/kg IV over 10 to 15 minutes.2.Administer furosemide (0.7 mg/kg IV) 15 minutes after mannitol to prolong the effects of mannitol.3.Administer hypertonic saline at 1.0 to 2.0 mL/kg IV over 10 to 15 minutes.4.Repeat osmotic therapy up to every 6 hours unless the animal becomes dehydrated or hypovolemic.5.Evaluate packed cell volume (PCV) and total solids (TS) before administration of osmotic therapy to evaluate hydration status.6.Do not use osmotic therapy in dehydrated, hypovolemic animals, or in animals with decreased cardiac function.B.Prednisone (0.5 to 1.0 mg/kg PO, IV) can be administered to reduce peritumoral (vasogenic) edema and inflammation.C.Anticonvulsants are administered for seizures.1.Phenobarbital (2.0 to 4.0 mg/kg PO, IM, IV BID) is usually the first option.2.KBr (30 mg/kg PO SID) may also be added.3.Animals with intracranial neoplasia may become extremely sedate with anticonvulsants.4.Dosages less than the recommended amount may be used initially to avoid extreme sedation.II.Definitive treatment includes surgery and/or radiation therapy.A.Surgery allows for tumor resection or cytoreduction and provides a histological diagnosis.B.Surgery often is reserved for tumors that are extraaxial (superficial), and more easily approached and removable.C.Radiation therapy (alone or in combination with surgery) has been shown to increase survival time ([@bib3]; [@bib6]).D.Overall prognosis is fair to guarded and depends on the location and type of tumor.

CRANIAL TRAUMA {#cesec239}
==============

 {#cesec240}

###  {#cesec241}

#### Definition and Causes {#cesec242}

I.Neurological dysfunction secondary to head trauma is caused by brain contusion, laceration, edema, or hemorrhage.II.Trauma may occur from a fall, automobile accident, or blunt or penetrating injuries.

#### Pathophysiology {#cesec243}

I.Depressed skull fractures may cause compression and injury to underlying brain parenchyma.II.Angular acceleration of the brain can cause diffuse, axonal injury.III.The impact of the brain against the skull results in coup (occurring in tissue under the area of impact) and contrecoup injuries (occurring in tissue on the side opposite the impact).IV.Hemorrhage and hematoma formation can compress brain parenchyma.V.The end result is vasogenic edema of the brain.

#### Clinical Signs {#cesec244}

I.Signs may be indicative of focal or diffuse brain disease.II.Prosencephalic injury may result in loss of consciousness in severe cases, but more frequently leads to circling, altered mentation, and contralateral postural reaction deficits, blindness, and facial hypalgesia.III.Brainstem injury typically causes altered mentation (depression, obtundation, or sometimes a comatose state), pupillary changes, and loss of conjugate eye movementsIV.Cerebellovestibular injury can result in dysmetria, cerebellar or vestibular ataxia, dysequilibrium, head tilt, and spontaneous or positional nystagmus.V.Evidence of progressive clinical signs suggests cerebral edema, herniation, or hematoma formation.

#### Diagnosis {#cesec245}

I.Signs of brain dysfunction in an animal known to have suffered an injury are suggestive.II.Abrasions, penetrating wounds, or other evidence of head trauma are supportive.III.Although difficult to interpret, radiographs may reveal skull fractures.IV.MRI or CT can identify skull fractures, areas of hemorrhage, hematoma formation, and edema within the brain.

#### Differential Diagnosis {#cesec246}

I.Other disorders are considered if trauma was not wit-nessed or if external evidence of trauma is absent.II.Consider metabolic and toxic encephalopathies, as well as inflammatory, vascular, and neoplastic disorders.

#### Treatment and Monitoring {#cesec247}

I.Nonspecific therapy is often initiated before or in conjunction with specific therapies.A.Ensure airway patency, adequate ventilation, and stabilize cardiovascular function.B.Institute fluid therapy to correct any hypovolemia and associated hypotension.C.Provide oxygen to prevent further tissue hypoxia.D.Turn recumbent animals every 6 hours, and keep them clean and well padded.E.Provide nutritional support after they are stabilized.II.Specific therapy is directed at reducing cerebral edema and intracranial pressure.A.Recumbent animals are positioned with their heads slightly elevated (15 to 30 degrees).B.Osmotic therapy is started for cerebral edema.1.Mannitol 0.25 to 1.0 g/kg IV over 10 to 15 minutes2.Hypertonic saline 7% 1 to 5 mL/kg IV over 3 to 5 minutes3.Furosemide (0.7 mg/kg IV) can be given 15 minutes after mannitol to prolong its effect.4.Osmotic therapy can be repeated every 6 to 8 hours unless dehydration or hypernatremia develops.5.Electrolytes, PCV, and TS are monitored closely with osmotic therapy.C.Osmotic therapy is contraindicated in hypovolemic animals and those with clinical signs suggestive of active intracranial hemorrhage.D.Surgery is indicated for depressed skull fractures or if the animal\'s condition deteriorates despite medical management.III.Prognosis depends on the severity and location of the injury.IV.Although most improvements are seen within the first month of the injury, recovery may take weeks to months.V.Long-term sequelae may include seizures and persistent neurological deficits.

[^1]: *MRI*, Magnetic resonance imaging; *EMG*, electromyography.

[^2]: Cerebellar ataxia (dysmetria, hypermetria), intention tremors of the head, wide based stance, and occasionally lack of menace with normal vision.

[^3]: *DNA*, Deoxyribonucleic acid; *MPS,* mucopolysaccharidosis; *PAS*, periodic acid Schiff.

[^4]: *EMG,* Electromyography.

[^5]: DNA testing, oligosaccharide analysis, organic acid and metabolite screening in the urine, and serum lysosomal enzyme assays are performed by PennGenn/Section of Medical Genetics, Veterinary Hospital 4006, University of Pennsylvania, 3900 Delancey Street, Philadelphia, PA 19104.

[^6]: Lysosomal Diseases Testing Laboratory, Jefferson Medical College, Department of Neurology, 1020 Locust Street, Room 394, Philadelphia, PA 19107.
